| (単位:千ドル) | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 |
|---|---|---|---|---|---|---|---|---|
| 研究開発費 | 4,980 | 6,325 | 6,269 | 7,683 | 25,758 | 35,289 | 60,594 | 104,203 |
| 営業費用 | 5,952 | 7,932 | 7,805 | 9,556 | 28,355 | 39,391 | 66,230 | 113,266 |
| 営業利益 | -5,953 | -7,933 | -7,806 | -9,557 | -28,356 | -39,392 | -66,231 | -113,267 |
| 経常(税引前)利益 | -6,252 | -7,481 | -7,360 | -9,475 | -29,606 | -40,371 | -63,780 | -111,780 |
| 法人税等合計 | 0 | 0 | 0 | - | - | - | - | - |
| 実効税率(%) | - | - | - | - | - | |||
| 純利益 | -6,252 | -7,481 | -7,360 | -9,475 | -29,606 | -40,371 | -63,780 | -111,780 |
| 一株あたり利益 | - | - | - | - | - | -2.64 | -2.69 | -2.83 |
| 希薄化後一株あたり利益 | - | - | - | - | - | -2.64 | -2.69 | -2.83 |